Open Access
| Issue |
BIO Web Conf.
Volume 124, 2024
The 2nd International Conference on Food Science and Bio-medicine (ICFSB 2024)
|
|
|---|---|---|
| Article Number | 02017 | |
| Number of page(s) | 9 | |
| Section | Biomedical and Clinical Medical Research | |
| DOI | https://doi.org/10.1051/bioconf/202412402017 | |
| Published online | 23 August 2024 | |
- Fisher M C, Hawkins N J, Sanglard D, et al. Worldwide emergence of resistance to antifungal drugs challenges human health and food security[J]. Science, 2018, 360(6390):739–742. [CrossRef] [PubMed] [Google Scholar]
- Samaranayake L P, Fidel P L, Naglik J R, et al. Fungal infections associated with HIV infection[J]. Oral Dis, 2002, 8 Suppl 2:151–160. [CrossRef] [PubMed] [Google Scholar]
- Kojic E M, Darouiche R O. Candida infections of medical devices[J]. Clin Microbiol Rev, 2004, 17(2):255–267. [CrossRef] [PubMed] [Google Scholar]
- Pfaller M A, Diekema D J. Epidemiology of invasive mycoses in North America[J]. Crit Rev Microbiol, 2010, 36(1):1–53. [CrossRef] [PubMed] [Google Scholar]
- Pfaller M A, Diekema D J, Turnidge J D, et al. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016[J]. Open Forum Infect Dis, 2019, 6(Suppl 1):S79–S94. [CrossRef] [PubMed] [Google Scholar]
- Silver P M, Oliver B G, White T C. Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism[J]. Eukaryot Cell, 2004, 3(6):1391–1397. [CrossRef] [PubMed] [Google Scholar]
- Brown G D, Denning D W, Levitz S M. Tackling human fungal infections[J]. Science, 2012, 336(6082):647. [CrossRef] [PubMed] [Google Scholar]
- Rentz A M, Halpern M T, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness[J]. Clin Infect Dis, 1998, 27(4):781–788. [CrossRef] [PubMed] [Google Scholar]
- Labelle A J, Micek S T, Roubinian N, et al. Treatment- related risk factors for hospital mortality in Candida bloodstream infections[J]. Crit Care Med, 2008, 36(11):2967–2972. [CrossRef] [PubMed] [Google Scholar]
- Osoba A O, Al-Mowallad A W, Mcalear D E, et al. Candidemia and the susceptibility pattern of Candida isolates in blood[J]. Saudi Med J, 2003, 24(10):1060–1063. [PubMed] [Google Scholar]
- Al-Dorzi H M, Sakkijha H, Khan R, et al. Invasive Candidiasis in Critically Ill Patients: A Prospective Cohort Study in Two Tertiary Care Centers[J]. J Intensive Care Med, 2020, 35(6):542–553. [CrossRef] [PubMed] [Google Scholar]
- Roux D, Gaudry S, Khoy-Ear L, et al. Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail[J]. Crit Care Med, 2013, 41(9):e191–e199. [CrossRef] [PubMed] [Google Scholar]
- Rajendran R, Sherry L, Nile C J, et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013[J]. Clin Microbiol Infect, 2016, 22(1):87–93. [CrossRef] [PubMed] [Google Scholar]
- Morrell M, Fraser V J, Kollef M H. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality[J]. Antimicrob Agents Chemother, 2005, 49(9):3640–3645. [CrossRef] [PubMed] [Google Scholar]
- Bouza E, Burillo A, Munoz P, et al. Mixed bloodstream infections involving bacteria and Candida spp[J]. J Antimicrob Chemother, 2013, 68(8):1881–1888. [CrossRef] [PubMed] [Google Scholar]
- Toda M, Williams S R, Berkow E L, et al. PopulationBased Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016[J]. MMWR Surveill Summ, 2019, 68(8):1–15. [CrossRef] [PubMed] [Google Scholar]
- Chen X C, Xu J, Wu D P. Clinical characteristics and implications of mixed candida/bacterial bloodstream infections in patients with hematological diseases[J]. Eur J Clin Microbiol Infect Dis, 2020, 39(8):1445–1452. [CrossRef] [PubMed] [Google Scholar]
- Citiulo F, Jacobsen I D, Miramon P, et al. Candida albicans scavenges host zinc via Pra1 during endothelial invasion[J]. PLoS Pathog, 2012, 8(6):e1002777. [CrossRef] [PubMed] [Google Scholar]
- Luo S, Dasari P, Reiher N, et al. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments[J]. Mol Immunol, 2018, 93:266–277. [CrossRef] [PubMed] [Google Scholar]
- Luo S, Dasari P, Reiher N, et al. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments[J]. Mol Immunol, 2018, 93:266–277. [CrossRef] [PubMed] [Google Scholar]
- Fourie R, Kuloyo O O, Mochochoko B M, et al. Iron at the Centre of Candida albicans Interactions[J]. Front Cell Infect Microbiol, 2018, 8:185. [CrossRef] [PubMed] [Google Scholar]
- Ramanan N, Wang Y. A high-affinity iron permease essential for Candida albicans virulence[J]. Science, 2000, 288(5468):1062–1064. [CrossRef] [PubMed] [Google Scholar]
- Li L, Liao Z, Yang Y, et al. Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans[J]. PLoS One, 2018, 13(2):e192328. [Google Scholar]
- Kimura S I, Kameda K, Harada K, et al. Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group[J]. Transplant Cell Ther, 2022, 28(4):201–209. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.